ProCE Banner Activity

TKIs for Advanced HCC in the Second Line and Beyond

Podcast Episodes
In this podcast episode, experts Josep M. Llovet, MD, PhD, and Univ. Prof. Markus Peck-Radosavljevic, MD, MBA, discuss the role of tyrosine kinase inhibitors in treating patients with advanced HCC in the second line and beyond.

Released: February 22, 2022

Expiration: February 21, 2023

No longer available for credit.


Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by an educational grant from

Bayer Healthcare Pharma